Experts warn of risks from govt price floor on key pharma inputs
NEW DELHI: Experts in the pharma industry have raised their concerns over the government’s move to notify a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers. Experts said a chain-wide MIP on Pen-G, 6-APA and amoxicillin would raise costs across essential medicines, disrupt government tenders…
